Thirty-day outcomes of endovascular repair of Stanford type B aortic dissection in patients with chronic obstructive pulmonary disease
Vascular · 2025
DOI: 10.1177/17085381241298732 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Vascular, 2025. Verfasst von Renxi Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: The George Washington University School of Medicine and Health Sciences, Washington, DC, USA. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Endovascular Procedures, Aortic Dissection, Blood Vessel Prosthesis Implantation. Die Arbeit nennt 18 Literaturangaben.
Themen: COPD
Abstract (Originalsprache)
Background
Thoracic Endovascular Aortic Repair (TEVAR) has revolutionized the surgical treatment for Stanford type B aortic dissection (TBAD). While chronic obstructive pulmonary disease (COPD) is associated with worse outcomes in major surgeries, the specific outcomes of TEVAR in patients with COPD have not been extensively explored. This study aimed to evaluate the 30-day postoperative outcomes of COPD patients undergoing TEVAR for TBAD utilizing data from a multi-institutional national registry.
Methods
Patients who underwent TEVAR for TBAD were identified in the ACS-NSQIP database from 2005 to 2022. A 1:3 propensity-score matching was used to match demographics and preoperative characteristics between patients with and without COPD. Thirty-day postoperative outcomes were compared.
Results
There were 172 (9.56%) and 1628 (90.44%) COPD and non-COPD patients who underwent TEVAR for TBAD, respectively. Patients with COPD had a higher comorbidity burden. After the propensity-score matching, all 172 COPD patients were matched to 440 non-COPD patients. COPD and non-COPD patients had comparable mortality rates (10.12% vs 6.82%, p = .18). However, COPD patients had a higher risk of pulmonary complications (20.83% vs 13.18%, p = .02). All other 30-day outcomes were similar between the two groups.
Conclusion
COPD patients had 58.04% higher pulmonary complications while all other 30-day outcomes were comparable to their non-COPD counterparts. Therefore, close monitoring and timely intervention for pulmonary complications in COPD patients can be important after TEVAR for TBAD. Future studies should investigate long-term outcomes among these COPD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
- Division of Vascular Surgery, Department of Surgery, The George Washington University Hospital, Washington, DC, USA.
ORCID-Profile: Renxi Li
Zitieren
APA
Li, R., Sidawy, A., & Nguyen, B. N. (2025). Thirty-day outcomes of endovascular repair of Stanford type B aortic dissection in patients with chronic obstructive pulmonary disease. Vascular. https://doi.org/10.1177/17085381241298732
Vancouver
Li R, Sidawy A, Nguyen BN. Thirty-day outcomes of endovascular repair of Stanford type B aortic dissection in patients with chronic obstructive pulmonary disease. Vascular. 2025. doi:10.1177/17085381241298732
BibTeX
@article{Li2025,
author = {Li, Renxi and Sidawy, Anton and Nguyen, Bao-Ngoc},
title = {Thirty-day outcomes of endovascular repair of Stanford type B aortic dissection in patients with chronic obstructive pulmonary disease},
journal = {Vascular},
year = {2025},
doi = {10.1177/17085381241298732}
}
EUVIMED